CRYO CELL INTERNATIONAL INC
For the period ended Feb 29, 2024. Filed Apr 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Feb 29, 2024 · Filed Apr 15, 2024
CCEL$4.87-0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Deficit
| Additional · Total | |||||||
|---|---|---|---|---|---|---|---|
| Common Stock · Paid-In · Treasury · Accumulated · Stockholders' | |||||||
| Shares · Amount · Capital · Stock · Deficit · Deficit | |||||||
| Balance at November 30, 2023 | 14,849,246 | $148,492 | $43,411,143 | $(23,431,685) | $(31,159,182) | $(11,031,232) | |
| Compensatory element of stock options | 307,355 | 307,355 | |||||
| Treasury stock | (170,376) | (170,376) | |||||
| Net income | 556,241 | 556,241 | |||||
| Balance at February 29, 2024 | 14,849,246 | $148,492 | $43,718,498 | $(23,602,061) | $(30,602,941) | $(10,338,012) | |
| Additional · Total | |||||||
| Common Stock · Paid-In · Treasury · Accumulated · Stockholders' | |||||||
| Shares · Amount · Capital · Stock · Deficit · Deficit | |||||||
| Balance at November 30, 2022 | 14,848,001 | $148,480 | $42,597,380 | $(22,632,649) | $(21,637,513) | $(1,524,302) | |
| Compensatory element of stock options | 313,174 | 313,174 | |||||
| Treasury stock | (243,201) | (243,201) | |||||
| Net income | 766,812 | 766,812 | |||||
| Balance at February 28, 2023 | 14,848,001 | $148,480 | $42,910,554 | $(22,875,850) | $(20,870,701) | $(687,517) | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.